136 related articles for article (PubMed ID: 12118246)
1. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease.
Xiong D; Lee GH; Badorff C; Dorner A; Lee S; Wolf P; Knowlton KU
Nat Med; 2002 Aug; 8(8):872-7. PubMed ID: 12118246
[TBL] [Abstract][Full Text] [Related]
2. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy.
Khairallah M; Khairallah R; Young ME; Dyck JR; Petrof BJ; Des Rosiers C
J Mol Cell Cardiol; 2007 Aug; 43(2):119-29. PubMed ID: 17583724
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
5. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects.
Klingel K; Rieger P; Mall G; Selinka HC; Huber M; Kandolf R
Lab Invest; 1998 Oct; 78(10):1227-37. PubMed ID: 9800948
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
[TBL] [Abstract][Full Text] [Related]
7. Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.
Bostick B; Yue Y; Long C; Duan D
Circ Res; 2008 Jan; 102(1):121-30. PubMed ID: 17967782
[TBL] [Abstract][Full Text] [Related]
8. Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.
Barnabei MS; Sjaastad FV; Townsend D; Bedada FB; Metzger JM
Sci Transl Med; 2015 Jul; 7(294):294ra106. PubMed ID: 26136477
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
Lee GH; Badorff C; Knowlton KU
Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
11. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy.
Xiong D; Yajima T; Lim BK; Stenbit A; Dublin A; Dalton ND; Summers-Torres D; Molkentin JD; Duplain H; Wessely R; Chen J; Knowlton KU
Circulation; 2007 Jan; 115(1):94-102. PubMed ID: 17190866
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin: from non-ischemic cardiomyopathy to ischemic cardiomyopathy.
Zheng QS; Guo WG; Lu ZF; Shi XQ; Su FF; Li H
Med Hypotheses; 2008 Sep; 71(3):434-8. PubMed ID: 18562127
[TBL] [Abstract][Full Text] [Related]
13. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
[TBL] [Abstract][Full Text] [Related]
14. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
[TBL] [Abstract][Full Text] [Related]
15. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice.
De Sarro G; Ibbadu GF; Marra R; Rotiroti D; Loiacono A; Donato Di Paola E; Russo E
Neurosci Res; 2004 Sep; 50(1):37-44. PubMed ID: 15288497
[TBL] [Abstract][Full Text] [Related]
16. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
17. Unsolved medical issues and new targets for further research in viral myocarditis and dilated cardiomyopathy.
Knowlton KU
Ernst Schering Res Found Workshop; 2006; (55):19-35. PubMed ID: 16329655
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic heart failure blocked by membrane sealant poloxamer.
Yasuda S; Townsend D; Michele DE; Favre EG; Day SM; Metzger JM
Nature; 2005 Aug; 436(7053):1025-9. PubMed ID: 16025101
[TBL] [Abstract][Full Text] [Related]
20. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
